Country: Ástralía
Tungumál: enska
Heimild: Department of Health (Therapeutic Goods Administration)
Erythromycin
Mayne Pharma International Pty Ltd
Medicine Registered
V1.0 _ _ Page 1 MAYNE PHARMA ERYTHROMYCIN CAPSULES erythromycin _(eh-rith-roe-MYE-sin) _ _ _ CONSUMER MEDICINE INFORMATION _Date of Dispensing _ _Consumer Name _ _Pharmacist Name _ _Consumer Address _ _Pharmacist Address _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Mayne Pharma Erythromycin Capsules. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking erythromycin against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT ERYTHROMYCIN CAPSULES ARE USED FOR This medicine is an antibiotic used to: treat infections in different parts of the body caused by bacteria prevent infections in patients with a history of rheumatic disease who may be allergic to penicillin. This medicine is an antibiotic which belongs to a group of medicines called macrolides. It works by killing or stopping the growth of bacteria which cause infections. This medicine will not work against viral infections such as colds or flu. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is not addictive. This medicine is available only with a doctor’s prescription. BEFORE YOU TAKE ERYTHROMYCIN CAPSULES _ _ _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE ERYTHROMYCIN CAPSULES IF YOU HAVE AN ALLERGY TO: any medicine containing erythromycin any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or Lestu allt skjalið
Product Information – Australia Version 2.0 Page 1 MAYNE PHARMA ERYTHROMYCIN CAPSULES NAME OF THE MEDICINE The active ingredient in Mayne Pharma Erythromycin Capsules is erythromycin. The chemical structure of erythromycin is shown below CAS No. 114-07-8 DESCRIPTION Mayne Pharma Erythromycin Capsules contain enteric coated pellets of erythromycin for oral administration. The enteric coating on the pellets covers the bitter tasting erythromycin as well as protects the erythromycin from gastric acid destruction during the passage through the stomach. Mayne Pharma Erythromycin Capsules also contain the following inactive ingredients: lactose, potassium phosphate monobasic, povidone, water-purified, cellacephate, diethyl phthalate, gelatine, shellac, erythrosine, indigo carmine (132), sunset yellow (110), carbon black (153). Erythromycin is produced by a strain of _Streptomyces erythreus_ and belongs to the macrolide group of antibiotics. It is basic and readily forms salts with acids. CLINICAL PHARMACOLOGY Orally administered erythromycin is readily absorbed in the microbiologically active form. Interindividual variations in the absorption of erythromycin are, however, observed and some patients do not achieve acceptable serum levels. Absorption may be interfered with by the presence of food in the stomach. Optimal conditions for stability in the presence of gastric secretion and for complete absorption are attained when Mayne Pharma Erythromycin Capsules are taken on an empty stomach. After administration of the third dose of 2 x 175mg erythromycin capsules to adults, a mean peak serum level of 2.01 ± 0.69mcg/ml was attained in approximately 2-4 hours. This is comparable to peak serum levels achieved with 2 x 250mg of other formulations of erythromycin. Erythromycin is bound to plasma proteins to the extent of approximately 75%. It diffuses readily into most body fluids Lestu allt skjalið